Some opportunities happen only once in a lifetime - like a job where you have the chance to change lives. At Alexion, people living with rare and devastating diseases are our Guiding Star. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. We value the uniqueness and diversity of our employees and recognize that nurturing the diverse perspectives and strengths of our people translates into innovative breakthroughs for patients.
External Scientific Engagement Head PipelineLocation: ALXN Global R&D Hub (Barcelona)
Reports To: Head of External Scientific Engagement, Global R&D Hub
This is what you will do:The ESE Head Pipeline is a scientific resource based in one of the Alexion R&D Hubs, who strategically builds & supports the Global External Scientific Engagement Strategy for the early stage assets of Alexion's portfolio/pipeline in his/her Therapeutic Area. The ESE Head Pipeline will have key responsibility to collaborate with ALXN Global stakeholders to identify, engage and establish strong collegial and professional relationships/partnerships with Key Studies Investigators and Key Opinion Leaders (KOLs) globally - through Strategic Consulting Groups & Global events - and collect relevant actionable insights in new fields of engagement. The ESE Head Pipeline will work very closely with Global Clinical Development (R&D TA Head & Medical Directors), Global Clinical & Country Operations, Global Medical Affairs, and all cross-functional Global stakeholders to ensure the successful design and performance of Alexion´s clinical trials, from early phases of development up to successful confirmatory studies. He/she will also maintain a very close collaboration with all Medical Advisor Pipeline (MAP) in the Countries, to ensure proper External Scientific Engagement at country level, and regular bi-directional updates and alignment on strategic medical plans for each individual study at the country level. The ESE Head Pipeline will report directly to the Head of External Scientific Engagement, Global R&D Hub in Barcelona.
You will be responsible for:Global KEEs Engagement in key indications in the TA & Long-term PartnershipDevelop and maintain the highest scientific and medical expertise in the relevant fields and be acknowledged internally and externally as an expert & resource in the assigned therapeutic area/indications.Identify and address relevant insights gaps with the SCG and KEEs Communities, and relay those to Global Stakeholders & MAP team.Obtain valuable and actionable insights from the field to be shared with internal stakeholders.Ensure timely and informative scientific/medical exchanges with customers and internal partners, in accordance with compliance policies and with legal requirements.Global R&D Clinical Trials SupportDrive identification of potential sites and investigators for clinical trials.Enhance clinical operations efforts to improve recruitment & retention by possible education, training, MAP clinical discussions with site's team, e.g. on in- and exclusion criteria.Strong collaboration with (but not limited to): Global Clinical Development, Global Clinical Operations & Country Operations, Global Medical Affairs teams, Global Project Team cross-functional members.You will need to have:MD or Pharma D with expertise in the desired Therapeutic AreaMinimum 10 years of combined experience in Medical Affairs, Clinical Development or KEEs engagement rolesKnowledge of Clinical Development, Healthcare system and Market access environmentPrevious experience in rare diseases is an advantageWillingness to travel (up to 30 % of time)Fluency in English is a must, other relevant languages is an advantageWe would prefer for you to have:Patient centricityExcellent communication and leadership skillsCapacity and willingness to work cross-functionallyProven capacity to:
Establish and develop internal and external networksPlan and manage complex projectsWork independently and proactivelyAct as a team player in multi-disciplinary & multi-cultural settingsPositive attitude during challenging situationsAstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. If you're interested in career opportunities with AstraZeneca, click here.
#J-18808-Ljbffr
